AVRO.OB: Summary for AVERION INTL CORP - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Tuesday, November 24, 2009, 5:24am EST - Canadian Markets open in 4 hours and 6 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Averion International Corp. (AVRO.OB)

On Nov 23: 0.008 USD 0.00 (0.00%)

MORE ON AVRO.OB

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

AVERION INTL CORP (OTC BB:AVRO.OB) Delayed quote data

Last Trade:	0.008 USD
Trade Time:	Nov 23
Change:	0.00 (0.00%)
Prev Close:	0.008
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	N/A

Day's Range:	N/A - N/A
52wk Range:	0.01 - 0.09
Volume:	0
Avg Vol (3m):	35,555.6
Market Cap:	5.11M
P/E (ttm):	N/A
EPS (ttm):	-0.053
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add AVRO.OB to Portfolio

Download Data

HEADLINES

•	AVERION INTERNATIONAL CORP. Financials
	EDGAR Online Financials (Thu, Nov 19)

•	AVERION INTERNATIONAL CORP. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	Averion Announces Going Private Transaction
	Business Wire (Fri, Sep 4)

•	AVERION INTERNATIONAL CORP. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Aug 7)

•	AVERION INTERNATIONAL CORP. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and
	EDGAR Online (Tue, Aug 4)

•	AVERION INTERNATIONAL CORP. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events, Financial St
	EDGAR Online (Thu, Jul 30)

•	AVERION INTERNATIONAL CORP. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Tue, May 12)

•	AVERION INTERNATIONAL CORP. Files SEC form 8-K/A, Financial Statements and Exhibits
	EDGAR Online (Wed, May 6)

•	AVERION INTERNATIONAL CORP. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements a
	EDGAR Online (Tue, Mar 31)

•	AVERION INTERNATIONAL CORP. Files SEC form 10-K, Annual Report
	EDGAR Online (Mon, Mar 30)

More Headlines for AVRO.OB...

ANALYST

EPS Est (next year) (Dec-69) :	N/A
EPS Est (in 2 years) (Dec-69) :	N/A
Avg Rec (current)*:	N/A
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Averion International Corp., an international clinical research organization, focuses on providing clinical research services and solutions for the drug development lifecycle.

Full Company Profile

Add to Portfolio

Email to a Friend

•